Skip to content

Kenvue Belgium

Active
Public limited companyfounded 196858 yrs activeMichel De Braeystraat 52, 2000 Antwerpen, BelgiumKBO/BCE: BE 0401.955.033
Summary

Kenvue Belgium has been active since 1968 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €14.2m and a net result of €2.0m. Equity remains stable across the filed fiscal years (±0.5% per year). Its solvency ranks better than 49% of 6016 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460NACE 51460
1 site
Size
€32.0mtotal assets 2025
Staff
66.1 FTE
Equity
€14.2m
Profit
€2.0m
Financial health
97 Excellent Checked score 2025
Bankruptcy chance 12 m
< 0.1%
Structure
Parent
Kenvue Inc.
Board
3 members
Auditor: PricewaterhouseCoopers Reviseurs d'EntreprisesAccounts 29 d early
Why 97- 1 of the last 3 late+ Founded in 1968+ Size: 66.1 FTE, total assets €32.0m+ Liquidity: current ratio 1.81, cash €11.6mShow the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Better than 78% of its sector peers (NACE 46, medium-sized)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Strong
Solvency 69+12
equity 44.4% of total assets
Liquidity 68-5
short-term debt 54.4% · cash 36.3%
Profitability 77-1
return on assets 6.3%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (746 companies)
Last 24 months 11-2024: 0.5% 12-2024: 0.5%● 0.0% vs 11-2024 01-2025: 0.5%▼ -0.6% vs 12-2024 02-2025: 0.5%● 0.0% vs 01-2025 03-2025: 0.5%▼ -0.6% vs 02-2025 04-2025: 0.5%▲ +1.7% vs 03-2025 05-2025: 0.5%▲ +5.6% vs 04-2025highest value 06-2025: 0.3%▼ -48.4% vs 05-2025 07-2025: 0.3%▲ +5.4% vs 06-2025 08-2025: < 0.1%▼ -82.9% vs 07-2025 09-2025: < 0.1%● 0.0% vs 08-2025 10-2025: < 0.1%● 0.0% vs 09-2025 11-2025: < 0.1%● 0.0% vs 10-2025 12-2025: < 0.1%● 0.0% vs 11-2025 01-2026: < 0.1%▼ -2.1% vs 12-2025 02-2026: < 0.1%● 0.0% vs 01-2026 03-2026: < 0.1%● 0.0% vs 02-2026 04-2026: < 0.1%● 0.0% vs 03-2026 05-2026: < 0.1%● 0.0% vs 04-2026 06-2026: < 0.1%▲ +2.2% vs 05-2026 07-2026: < 0.1%▲ +2.1% vs 06-2026 08-2026: < 0.1%▼ -10.4% vs 07-2026lowest value 09-2026: < 0.1%● 0.0% vs 08-2026lowest value 10-2026: < 0.1%● 0.0% vs 09-2026lowest value
  • Founded in 1968 lowers the probability for this profile
  • Size: 66.1 FTE, total assets €32.0m lowers the probability for this profile
  • Liquidity: current ratio 1.81, cash €11.6m lowers the probability
  • 1 of the last 3 late raises the probability
Credit up to €1,350,000 at 30 days acceptable
Liquidity ample (current ratio 1.81 against 1.82 in 2024; short-term debt: 54.4% and cash: 36.3% of total assets), but 55.6% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 46, medium-sized). Better than this share of them on solvency 55%, liquidity 93%, profitability 83%, growth against the median 79%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 04-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Founded in 1968
In the bankruptcy model this factor lowers the probability for this profile.
KBO
lowers risk · Size: 66.1 FTE, total assets €32.0m
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.81, cash €11.6m
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
raises risk · 1 of the last 3 late
In the bankruptcy model this factor raises the probability.
NBB · filings
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €14.2m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
29 d early
2024
2 d early
2023
75 d late
2022
35 d early
2021
34 d early
2020
32 d early
2019
31 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 13 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 2 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
05-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · full…
  2. Appointment: PwC Bedrijfsrevisoren BV (statutory auditor)Permanent representative: Steven Van Bael
  3. Annual accounts filedfiscal year 2024 · full…

Key points

  • Positive: Among the best 11% on net resultsector median €114,682 · 5,959 companies €2.0m View
  • Controlled by Kenvue Inc.known shareholders 100% parent View
  • Active since 1968founded 01-01-1968 58 years View
  • Caution: Result fell in 2025from €2.7m to €2.0m ▼ 25.4% View

By topic

Financials

Fiscal year
2025
Total assets
€32.0m
Profit
€2.0m
Solvency
44.4%
Total assets▼ 14.8%
Net result
20182025
Go to Financials

Board & ownership

Board
3 members
Parent
Kenvue Inc.
Known shareholders
100%
Auditor
PricewaterhouseCoopers Reviseurs d'Entreprises
Go to Board & ownership

Timeline

Events
59
Since
2005
Next accounts
by 31-07-2027
  1. 02-07-2026Annual accounts filed
  2. 18-12-2025Appointment: PwC Bedrijfsrevisoren BV (statutory auditor)
  3. 29-07-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
01-01-1968
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
1
Purpose
Alle verrichtingen die betrekking hebben op de industrie en de handel in al haar vormen…
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.